companydata.dkcompanydata.dk

Abbott Medical Danmark A/S: Financial statements 2025

CVR: 17558501

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Abbott Medical Danmark A/S (CVR 17558501) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 198,838,342 and a net result of DKK 6,225,964 compared with DKK 7,897,543 the year before. That is an increase of 3.6% compared with the year before. The profit margin was 3.1%. Equity in the 2025 report amounted to DKK 46,327,156. The solvency ratio was 41.6%. The company had 23 employees in the financial year.

Revenue
DKK 198,838,342
Gross Profit
DKK 30,380,823
Profit/Loss
DKK 6,225,964
Equity
DKK 46,327,156
Total Assets
DKK 111,275,824
Employees
23

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025198.8M30.4M6.2M46.3M23
2024192M35.5M7.9M140.1M22
2023185.8M31.8M7.1M132.2M23
2022188.1M32.6M4.1M125.1M24
2021239.6M33.4M5.2M121.1M23

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Abbott Medical Danmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Abbott Medical Danmark A/S wins public contractDec 16, 2025

Abbott Medical Danmark A/S has won the tender "Iskæmi" issued by Region Hovedstaden worth 232,303,118 DKK.

Abbott Medical Danmark A/S: The 2024 annual report is outJun 27, 2025

Abbott Medical Danmark A/S has published its annual report for 2024. Revenue came to DKK 191,993,466, and the net result was DKK 7,897,543.

Abbott Medical Danmark A/S wins public contractJun 24, 2025

Abbott Medical Danmark A/S has won the tender "TAVI, selvekspanderende" issued by Region Hovedstaden worth 84,660,000 DKK.

Abbott Medical Danmark A/S wins public contractJun 6, 2025

Abbott Medical Danmark A/S has won the tender "Udbud af TAVI hjerteklapper" issued by Region Nordjylland worth 4,800 DKK.

Abbott Medical Danmark A/S wins public contractJun 3, 2025

Abbott Medical Danmark A/S has won the tender "Udbud af Varer til Spinal Cord Stimulation (SCS)" issued by Region Midtjylland worth 21,600,000 DKK.

Abbott Medical Danmark A/S wins public contractMay 8, 2025

Abbott Medical Danmark A/S has won the tender "Udbud af produkter til radiologisk intervention, perifer." issued by Region Nordjylland worth 1 DKK.

Abbott Medical Danmark A/S wins public contractApr 11, 2025

Abbott Medical Danmark A/S has won the tender "Udbud af Strukturelt Hjerte" issued by Region Hovedstaden worth 72,710,277 DKK.

Abbott Medical Danmark A/S wins public contractMar 11, 2025

Abbott Medical Danmark A/S has won the tender "Udbud af kardiologiske stent mv." issued by Region Nordjylland worth 42,104,368 DKK.

About Abbott Medical Danmark A/S

Abbott Medical Danmark A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 1994. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ST. JUDE MEDICAL DANMARK A/S and P.P.H.S.G. 209 A/S. The management consists of Mika Tapio Mustonen. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Mika Tapio Mustonen. The company is owned by ABBOTT LABORATORIES A/S. The company has 20 employees (2026). In 2025, the company reported revenue of DKK 198,838,342 and a net result of DKK 6,225,964 compared with DKK 7,897,543 the year before. Equity in the 2025 report amounted to DKK 46,327,156.

Source: annual report 2025, Danish Business Authority